Discover your next big idea for life sciences at PACK EXPO Las Vegas
Experience a breakthrough in life sciences packaging—explore solutions from 2,300 suppliers spanning all industries, all in one place this September

FDA Intervenes With Anti-Diarrhea Drug Packaging

To encourage proper dosage, the FDA is working with manufacturers to use single dose packaging for anti-diarrhea drugs.

Imodium / Image: HealthDay
Imodium / Image: HealthDay

According to a recent FDA MedWatch article, the FDA has been inundated with reports of serious heart problems and deaths linked to people taking higher than recommended doses of loperamide. More commonly known as Imodium, loperamide is an anti-diarrhea medication that acts on opioid receptors in the intestines to decrease the number of bowel movements. Apparently consumers are intentionally taking much more than the recommended dosage.

The FDA’s maximum approved daily dose for adults is 8 mg per day, but when more is taken it can lead to heart rhythm issues or even death. To prevent this, the FDA is working with manufacturers to implement the use of blister packs and other single dose packaging to minimize the number of doses in each package.

Break out of the ordinary: see what’s new in life sciences packaging
<strong>At PACK EXPO Las Vegas, you’ll see machinery in action and new tech from 2,300 suppliers, collaborate with experts and explore transformative solutions. Join us in September to experience a breakthrough for life sciences products.</strong>
REGISTER NOW & SAVE!
Break out of the ordinary: see what’s new in life sciences packaging
FDA warning letters surge - is your team prepared?
New guide reveals expert strategies to prevent regulatory issues and respond effectively to FDA enforcement actions in pharmaceutical and medical device manufacturing.
Read More
FDA warning letters surge - is your team prepared?